Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03643224 · ClinicalTrials.gov registry record · NA
DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
A NA study, sponsored by Medtronic Cardiac Ablation Solutions.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
NCT03643224: Completed NA study, sponsored by Medtronic Cardiac Ablation Solutions.
NCT03643224 is a NA study that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 376 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03643224, a NA study, has completed, sponsored by Medtronic Cardiac Ablation Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
Study Summary
The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
Primary Outcome
Participant count of a composite of safety events including: serious adverse events (SAEs), procedure and/or device-related significant pericardial effusion, severe or clinically symptomatic pulmonary vein stenosis and atrioesophageal fistula
Interventions
- DEVICE Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2018-09-19 |
| Est. Completion | 2024-10-31 |
| Phase | NA |
What the finished NCT03643224 record still lists
NCT03643224 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency Ablation is the first listed.
NCT03643224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03643224 about?
NCT03643224 is a clinical study titled "DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation". The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
What is the current status of trial NCT03643224?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2018-09-19. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT03643224?
The interventions under investigation include: Radiofrequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT03643224?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03643224's enrollment target sits among peer trials
376 274th of 2000 higher than 1,725 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI